Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Samuel T Workenhe, Jonathan Pol & Guido Kroemer. (2021) Tumor-intrinsic determinants of immunogenic cell death modalities. OncoImmunology 10:1.
Read now
Read now
Yang-Jie Hu, Jiang-Tao Zhong, Liang Gong, Si-Cong Zhang & Shui-Hong Zhou. (2020) Autophagy-Related Beclin 1 and Head and Neck Cancers. OncoTargets and Therapy 13, pages 6213-6227.
Read now
Read now
Eziafa I. Oduah & Steven R. Grossman. (2020) Harnessing the vulnerabilities of p53 mutants in lung cancer – Focusing on the proteasome: a new trick for an old foe?. Cancer Biology & Therapy 21:4, pages 293-302.
Read now
Read now
Peihua Luo, Zhifei Xu, Guanqun Li, Hao Yan, Yi Zhu, Hong Zhu, Shenglin Ma, Bo Yang & Qiaojun He. (2018) HMGB1 represses the anti-cancer activity of sunitinib by governing TP53 autophagic degradation via its nucleus-to-cytoplasm transport. Autophagy 14:12, pages 2155-2170.
Read now
Read now
Yoon Yang Jung, Yu Kyung Lee & Ja Seung Koo. (2016) The potential of Beclin 1 as a therapeutic target for the treatment of breast cancer. Expert Opinion on Therapeutic Targets 20:2, pages 167-178.
Read now
Read now
Articles from other publishers (62)
Eugenia Wulff-Fuentes, Jeffrey Boakye, Kaeley Kroenke, Rex R. Berendt, Carla Martinez-Morant, Michaela Pereckas, John A. Hanover & Stephanie Olivier-Van Stichelen. (2023) O-GlcNAcylation regulates OTX2’s proteostasis. iScience 26:11, pages 108184.
Crossref
Crossref
Maria Krivega, Jutta Zimmer, Anna Slezko, Petra Frank-Herrmann, Julia Rehnitz, Markus Hohenfellner, Markus Bettendorf, Marcin Luzarowski & Thomas Strowitzki. (2023) Genomic instability in individuals with sex determination defects and germ cell cancer. Cell Death Discovery 9:1.
Crossref
Crossref
Qitong Wu & Dipali Sharma. (2023) Autophagy and Breast Cancer: Connected in Growth, Progression, and Therapy. Cells 12:8, pages 1156.
Crossref
Crossref
Giulia D. S. Ferretti, Julia Quarti, Gileno dos Santos, Luciana P. Rangel & Jerson L. Silva. (2022) Anticancer Therapeutic Strategies Targeting p53 Aggregation. International Journal of Molecular Sciences 23:19, pages 11023.
Crossref
Crossref
Quanyi Jin, Wenbao Zuo, Qian Lin, Ting Wu, Cong Liu, Nian Liu, Jinxue Liu & Xuan Zhu. (2022) Zinc-doped Prussian blue nanoparticles for mutp53-carrying tumor ion interference and photothermal therapy. Asian Journal of Pharmaceutical Sciences 17:5, pages 767-777.
Crossref
Crossref
Ravichandran Rakesh, Loganathan Chandramani PriyaDharshini, Kunnathur Murugesan Sakthivel & Rajan Radha Rasmi. (2022) Role and regulation of autophagy in cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868:7, pages 166400.
Crossref
Crossref
Zheng Yang Lee, Chee Hong Leong, Krystal U. Ling Lim, Christopher Chun Sing Wong, Pornwasu Pongtheerawan, Sathiavani A. Arikrishnan, Kian Leong Tan, Jian Sheng Loh, May Lee Low, Chee Wun How, Yong Sze Ong, Yin Sim Tor & Jhi Biau Foo. (2022) Induction of Apoptosis and Autophagy by Ternary Copper Complex Towards Breast Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry 22:6, pages 1159-1170.
Crossref
Crossref
Entaz Bahar, Sun-Young Han, Ji-Ye Kim & Hyonok Yoon. (2022) Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components. Cancers 14:6, pages 1462.
Crossref
Crossref
Silvia Vega-Rubín-de-Celis. 2022. Autophagy in Health and Disease. Autophagy in Health and Disease
361
384
.
Heena Saini, Harshita Sharma, Sudeshna Mukherjee, Shibasish Chowdhury & Rajdeep Chowdhury. (2021) Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells. Cancer Cell International 21:1.
Crossref
Crossref
Seung Jae Hyeon, Jinyoung Park, Junsang Yoo, Su-Hyun Kim, Yu Jin Hwang, Seung-Chan Kim, Tian Liu, Hyun Soo Shim, Yunha Kim, Yakdol Cho, Jiwan Woo, Key-Sun Kim, Richard H. Myers, Hannah L. Ryu, Neil W. Kowall, Eun Joo Song, Eun Mi Hwang, Hyemyung Seo, Junghee Lee & Hoon Ryu. (2021) Dysfunction of X-linked inhibitor of apoptosis protein (XIAP) triggers neuropathological processes via altered p53 activity in Huntington’s disease. Progress in Neurobiology 204, pages 102110.
Crossref
Crossref
J. P. Jose Merlin, H. P. Vasantha Rupasinghe, Graham Dellaire & Kieran Murphy. (2021) Role of Dietary Antioxidants in p53-Mediated Cancer Chemoprevention and Tumor Suppression. Oxidative Medicine and Cellular Longevity 2021, pages 1-18.
Crossref
Crossref
Nicolas J. Niklaus, Igor Tokarchuk, Mara Zbinden, Anna M. Schläfli, Paola Maycotte & Mario P. Tschan. (2021) The Multifaceted Functions of Autophagy in Breast Cancer Development and Treatment. Cells 10:6, pages 1447.
Crossref
Crossref
Dennis M. Timmerman, Tessa L. Remmers, Sanne Hillenius & Leendert H. J. Looijenga. (2021) Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells—Relevance for Understanding (Germ Cell) Tumorigenesis. International Journal of Molecular Sciences 22:10, pages 5377.
Crossref
Crossref
Zhifei Xu, Wentong Wu, Hao Yan, Yuhuai Hu, Qiaojun He & Peihua Luo. (2021) Regulation of p53 stability as a therapeutic strategy for cancer. Biochemical Pharmacology 185, pages 114407.
Crossref
Crossref
Gabriella D’Orazi, Marco Cordani & Mara Cirone. (2020) Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies. Cellular and Molecular Life Sciences 78:5, pages 1853-1860.
Crossref
Crossref
Yong Shi, Erik Norberg & Helin Vakifahmetoglu-Norberg. (2021) Mutant p53 as a Regulator and Target of Autophagy. Frontiers in Oncology 10.
Crossref
Crossref
Lili Zhao, Wenxi Li, Xu Luo & Surui Sheng. (2020) The multifaceted roles of nucleophagy in cancer development and therapy. Cell Biology International 45:2, pages 246-257.
Crossref
Crossref
Jianyu Wang, Doudou Liu, Zhiwei Sun, Ting Ye, Jingyuan Li, Bin Zeng, Qiting Zhao & H. Rosie Xing. (2021) Autophagy augments the self-renewal of lung cancer stem cells by the degradation of ubiquitinated p53. Cell Death & Disease 12:1.
Crossref
Crossref
Wasim Feroz & Arwah Mohammad Ali Sheikh. (2020) Exploring the multiple roles of guardian of the genome: P53. Egyptian Journal of Medical Human Genetics 21:1.
Crossref
Crossref
Luni Emdad, Praveen Bhoopathi, Sarmistha Talukdar, Anjan K. Pradhan, Devanand Sarkar, Xiang-Yang Wang, Swadesh K. Das & Paul B. Fisher. (2020) Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic. Seminars in Cancer Biology 66, pages 140-154.
Crossref
Crossref
Milena Matuszczak & Maciej Salagierski. (2020) Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers. International Journal of Molecular Sciences 21:9, pages 3360.
Crossref
Crossref
Jiajing Cai, Jingruo Xia, Jiang Zou, Qiang Wang, Qiang Ma, Ru Sun, Hebin Liao, Lei Xu, Dongsheng Wang & Xiaolan Guo. (2020) The PI3K/mTOR dual inhibitor NVP‐BEZ235 stimulates mutant p53 degradation to exert anti‐tumor effects on triple‐negative breast cancer cells. FEBS Open Bio 10:4, pages 535-545.
Crossref
Crossref
Giovanni Blandino, Fabio Valenti, Andrea Sacconi & Silvia Di Agostino. (2020) Wild type- and mutant p53 proteins in mitochondrial dysfunction: emerging insights in cancer disease. Seminars in Cell & Developmental Biology 98, pages 105-117.
Crossref
Crossref
Hyun-Jung Moon, So-Young Park, Su-Hoon Lee, Chi-Dug Kang & Sun-Hee Kim. (2019) Nonsteroidal Anti-inflammatory Drugs Sensitize CD44-Overexpressing Cancer Cells to Hsp90 Inhibitor Through Autophagy Activation. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 27:7, pages 835-847.
Crossref
Crossref
Zhuo Wang, Cuiping Li, Yongli Li, Xingshuang Guo, Zhaoyu Yan, Fulian Gao & Changzheng Li. (2019) DpdtbA-Induced Growth Inhibition in Human Esophageal Cancer Cells Involved Inactivation of the p53/EGFR/AKT Pathway. Oxidative Medicine and Cellular Longevity 2019, pages 1-14.
Crossref
Crossref
Nerea Allende-Vega & Martin Villalba. (2019) Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells. Scientific Reports 9:1.
Crossref
Crossref
Fiamma Mantovani, Licio Collavin & Giannino Del Sal. (2018) Mutant p53 as a guardian of the cancer cell. Cell Death & Differentiation 26:2, pages 199-212.
Crossref
Crossref
Heena Saini, Ifrah Hakeem, Sudeshna Mukherjee, Shibasish Chowdhury & Rajdeep Chowdhury. (2019) Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells. Journal of Oncology 2019, pages 1-17.
Crossref
Crossref
Satomi Yamamoto & Tomoo Iwakuma. (2018) Regulators of Oncogenic Mutant TP53 Gain of Function. Cancers 11:1, pages 4.
Crossref
Crossref
Xiangbing Meng, Shujie Yang, Yujun Li, Yiyang Li, Eric J. Devor, Jianling Bi, Xinhao Wang, Shaikamjad Umesalma, Dawn E. Quelle, William H. Thiel, Kristina W. Thiel & Kimberly K. Leslie. (2018) Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations. Disease Markers 2018, pages 1-7.
Crossref
Crossref
Giovanni Blandino & Silvia Di Agostino. (2018) New therapeutic strategies to treat human cancers expressing mutant p53 proteins. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Crossref
Adouda Adjiri. (2018) Tracing the path of cancer initiation: the AA protein-based model for cancer genesis. BMC Cancer 18:1.
Crossref
Crossref
Dhanya Kalathil, Manu Prasad, Maharrish Chelladurai, Samu John & Asha S. Nair. (2018) Thiostrepton degrades mutant p53 by eliciting an autophagic response in SW480 cells. Journal of Cellular Physiology 233:10, pages 6938-6950.
Crossref
Crossref
Tatiana Denisenko, Anastasia Pivnyuk & Boris Zhivotovsky. (2018) p53-Autophagy-Metastasis Link. Cancers 10:5, pages 148.
Crossref
Crossref
Fernando M. Simabuco, Mirian G. Morale, Isadora C.B. Pavan, Ana P. Morelli, Fernando R. Silva & Rodrigo E. Tamura. (2018) p53 and metabolism: from mechanism to therapeutics. Oncotarget 9:34, pages 23780-23823.
Crossref
Crossref
Hyun-Jung Moon, Hak-Bong Kim, Su-Hoon Lee, So-Eun Jeun, Chi-Dug Kang & Sun-Hee Kim. (2018) Sensitization of multidrug-resistant cancer cells to Hsp90 inhibitors by NSAIDs-induced apoptotic and autophagic cell death. Oncotarget 9:13, pages 11303-11321.
Crossref
Crossref
Gokulapriya Govindarajalu, Murugan Selvam, Elango Palchamy & Sudhakar Baluchamy. (2017) N-terminal truncations of human bHLH transcription factor Twist1 leads to the formation of aggresomes. Molecular and Cellular Biochemistry 439:1-2, pages 75-85.
Crossref
Crossref
Julie Frentzel, Domenico Sorrentino & Sylvie Giuriato. (2017) Targeting Autophagy in ALK-Associated Cancers. Cancers 9:12, pages 161.
Crossref
Crossref
A. B. Pupyshev, T. A. Korolenko & M. A. Tikhonova. (2017) A Therapeutic Target for Inhibition of Neurodegeneration: Autophagy. Neuroscience and Behavioral Physiology 47:9, pages 1109-1127.
Crossref
Crossref
Ye Lei, Kai Liu, Lin Hou, Lianggong Ding, Yuhong Li & Lei Liu. (2017) Small chaperons and autophagy protected neurons from necrotic cell death. Scientific Reports 7:1.
Crossref
Crossref
Devrim Gozuacik, Yunus Akkoc, Deniz Gulfem Ozturk & Muhammed Kocak. (2017) Autophagy-Regulating microRNAs and Cancer. Frontiers in Oncology 7.
Crossref
Crossref
Giorgia Foggetti, Laura Ottaggio, Debora Russo, Paola Monti, Paolo Degan, Gilberto Fronza & Paola Menichini. (2017) Gambogic acid counteracts mutant p53 stability by inducing autophagy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1864:2, pages 382-392.
Crossref
Crossref
Marco Cordani, Giovanna Butera, Raffaella Pacchiana & Massimo Donadelli. (2017) Molecular interplay between mutant p53 proteins and autophagy in cancer cells. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1867:1, pages 19-28.
Crossref
Crossref
M Aggarwal, R Saxena, E Sinclair, Y Fu, A Jacobs, M Dyba, X Wang, I Cruz, D Berry, B Kallakury, S C Mueller, S D Agostino, G Blandino, M L Avantaggiati & F-L Chung. (2016) Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth. Cell Death & Differentiation 23:10, pages 1615-1627.
Crossref
Crossref
Marco Cordani, Elisa Oppici, Ilaria Dando, Elena Butturini, Elisa Dalla Pozza, Mercedes Nadal-Serrano, Jordi Oliver, Pilar Roca, Sofia Mariotto, Barbara Cellini, Giovanni Blandino, Marta Palmieri, Silvia Di Agostino & Massimo Donadelli. (2016) Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition. Molecular Oncology 10:7, pages 1008-1029.
Crossref
Crossref
Rebecca A. Jackson & Ee Sin Chen. (2016) Synthetic lethal approaches for assessing combinatorial efficacy of chemotherapeutic drugs. Pharmacology & Therapeutics 162, pages 69-85.
Crossref
Crossref
Luciana R. Gomes, Alexandre T. Vessoni & Carlos F.M. Menck. (2016) Microenvironment and autophagy cross-talk: Implications in cancer therapy. Pharmacological Research 107, pages 300-307.
Crossref
Crossref
J. Liu & J. Debnath. 2016.
1
53
.
Maria Paz Hernandez, Carolina Oses, Daniel Peña, Alfredo Criollo & Eugenia Morselli. 2016. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging
189
203
.
Da-wei Wang, Zhen-ju Peng, Guang-fang Ren & Guang-xin Wang. (2015) The different roles of selective autophagic protein degradation in mammalian cells. Oncotarget 6:35, pages 37098-37116.
Crossref
Crossref
Flore Kruiswijk, Christiaan F. Labuschagne & Karen H. Vousden. (2015) p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nature Reviews Molecular Cell Biology 16:7, pages 393-405.
Crossref
Crossref
Lorenzo Galluzzi, Federico Pietrocola, José Manuel Bravo‐San Pedro, Ravi K Amaravadi, Eric H Baehrecke, Francesco Cecconi, Patrice Codogno, Jayanta Debnath, David A Gewirtz, Vassiliki Karantza, Alec Kimmelman, Sharad Kumar, Beth Levine, Maria Chiara Maiuri, Seamus J Martin, Josef Penninger, Mauro Piacentini, David C Rubinsztein, Hans‐Uwe Simon, Anne Simonsen, Andrew M Thorburn, Guillermo Velasco, Kevin M Ryan & Guido Kroemer. (2015) Autophagy in malignant transformation and cancer progression. The EMBO Journal 34:7, pages 856-880.
Crossref
Crossref
Lexun Lin, Ying Qin, Heng Wu, Yang Chen, Shuo Wu, Xiaoning Si, Hui Wang, Tianying Wang, Xiaoyan Zhong, Xia Zhai, Lei Tong, Bo Pan, Fengmin Zhang, Zhaohua Zhong, Yan Wang & Wenran Zhao. (2015) Pyrrolidine dithiocarbamate inhibits enterovirus 71 replication by down-regulating ubiquitin–proteasome system. Virus Research 195, pages 207-216.
Crossref
Crossref
Lymor Ringer, Paul Sirajuddin, Lucas Tricoli, Sarah Waye, Muhammad Umer Choudhry, Erika Parasido, Angiela Sivakumar, Mary Heckler, Aisha Naeem, Iman Abdelgawad, Xuefeng Liu, Adam S. Feldman, Richard J. Lee, Chin-Lee Wu, Venkata Yenugonda, Bhaskar Kallakury, Anatoly Dritschilo, John Lynch, Richard Schlegel, Olga Rodriguez, Richard G. Pestell, Maria Laura Avantaggiati & Chris Albanese. (2014) The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells. Oncotarget 5:21, pages 10678-10691.
Crossref
Crossref
Wensheng Yan, Yong-Sam Jung, Yanhong Zhang & Xinbin Chen. (2014) Arsenic Trioxide Reactivates Proteasome-Dependent Degradation of Mutant p53 Protein in Cancer Cells in Part via Enhanced Expression of Pirh2 E3 Ligase. PLoS ONE 9:8, pages e103497.
Crossref
Crossref
A Garufi, D Pucci, V D’Orazi, M Cirone, G Bossi, M L Avantaggiati & G D’Orazi. (2014) Degradation of mutant p53H175 protein by Zn(II) through autophagy. Cell Death & Disease 5:5, pages e1271-e1271.
Crossref
Crossref
Vamsi K. Kolukula, Geetaram Sahu, Anton Wellstein, Olga C. Rodriguez, Anju Preet, Vito Iacobazzi, Gabriella D’Orazi, Chris Albanese, Ferdinando Palmieri & Maria Laura Avantaggiati. (2014) SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker. Oncotarget 5:5, pages 1212-1225.
Crossref
Crossref
Patricia A.J. Muller & Karen H. Vousden. (2014) Mutant p53 in Cancer: New Functions and Therapeutic Opportunities. Cancer Cell 25:3, pages 304-317.
Crossref
Crossref
Donatella Del Bufalo, Marianna Desideri, Teresa De Luca, Marta Di Martile, Chiara Gabellini, Valentina Monica, Simone Busso, Adriana Eramo, Ruggero De Maria, Michele Milella & Daniela Trisciuoglio. (2014) Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer. Molecular Cancer 13:1, pages 230.
Crossref
Crossref
Javier E. Girardini, Carolina Marotta & Giannino Del Sal. (2014) Disarming mutant p53 oncogenic function. Pharmacological Research 79, pages 75-87.
Crossref
Crossref
B Liu, X Wen & Y Cheng. (2013) Survival or death: disequilibrating the oncogenic and tumor suppressive autophagy in cancer. Cell Death & Disease 4:10, pages e892-e892.
Crossref
Crossref